KITE PHARMA INC's ticker is KITE and the CUSIP is 49803L109. A total of 252 filers reported holding KITE PHARMA INC in Q3 2017. The put-call ratio across all filers is 1.40 and the average weighting 1.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2017 | $2,376,000 | +78.9% | 13,213 | +3.1% | 0.13% | +17.3% |
| Q2 2017 | $1,328,000 | -5.8% | 12,813 | -28.7% | 0.11% | -21.4% |
| Q1 2017 | $1,410,000 | +110.1% | 17,960 | +20.0% | 0.14% | +72.8% |
| Q4 2016 | $671,000 | -6.9% | 14,968 | +16.0% | 0.08% | -15.6% |
| Q3 2016 | $721,000 | +9.7% | 12,904 | -1.8% | 0.10% | +4.3% |
| Q2 2016 | $657,000 | -30.1% | 13,147 | -35.8% | 0.09% | +58.6% |
| Q1 2016 | $940,000 | +39.1% | 20,466 | +86.5% | 0.06% | -31.8% |
| Q4 2015 | $676,000 | – | 10,972 | – | 0.08% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Wildcat Capital Management, LLC | 2,410,034 | $433,348,000 | 77.71% |
| COWEN INC. | 4,200,600 | $755,310,000 | 26.72% |
| Tyrus Capital S.A.M. | 1,314,812 | $236,416,000 | 18.49% |
| OMNI PARTNERS LLP | 661,711 | $118,982,000 | 15.19% |
| FNY Partners Fund LP | 379,510 | $68,239,000 | 11.61% |
| EQUITEC PROPRIETARY MARKETS, LLC | 240,100 | $43,172,000 | 10.15% |
| EQUITEC PROPRIETARY MARKETS, LLC | 227,500 | $40,907,000 | 9.62% |
| GARDNER LEWIS ASSET MANAGEMENT L P | 773,817 | $139,140,000 | 8.89% |
| Quad Capital Management Advisors LLC | 192,537 | $34,620,000 | 7.10% |
| Avoro Capital Advisors LLC | 496,983 | $89,363,000 | 6.93% |